BRPI0617045B8 - composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição - Google Patents

composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição

Info

Publication number
BRPI0617045B8
BRPI0617045B8 BRPI0617045A BRPI0617045A BRPI0617045B8 BR PI0617045 B8 BRPI0617045 B8 BR PI0617045B8 BR PI0617045 A BRPI0617045 A BR PI0617045A BR PI0617045 A BRPI0617045 A BR PI0617045A BR PI0617045 B8 BRPI0617045 B8 BR PI0617045B8
Authority
BR
Brazil
Prior art keywords
composition
preparing
present
acid derivative
cosmetic
Prior art date
Application number
BRPI0617045A
Other languages
English (en)
Inventor
Mallard Claire
Ferrara Eve
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36337580&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0617045(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Priority claimed from PCT/IB2006/003852 external-priority patent/WO2007031883A2/en
Publication of BRPI0617045A2 publication Critical patent/BRPI0617045A2/pt
Publication of BRPI0617045B1 publication Critical patent/BRPI0617045B1/pt
Publication of BRPI0617045B8 publication Critical patent/BRPI0617045B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição. a presente invenção refere-se a uma composição para aplicação tópica que compreende, em um meio fisiologicamente aceitável, pelo menos um derivado do ácido naftóico e pelo menos um composto do tipo polímero poliuretano ou seus derivados. a presente invenção se caracteriza pelo fato do referido derivado do ácido naftócio estar em uma forma dispersada na referida composição. a presente invenção tem aplicação em particular no campo da farmácia ou da cosmética humanas.
BRPI0617045A 2005-09-16 2006-09-15 composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição BRPI0617045B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0509493A FR2890861B1 (fr) 2005-09-16 2005-09-16 Compositions comprenant au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethanes ou des derives de celui-ci, leurs procede de preparation, et leur utilisation
FR0509493 2005-09-16
US72527905P 2005-10-12 2005-10-12
US60/725,279 2005-10-12
PCT/IB2006/003852 WO2007031883A2 (en) 2005-09-16 2006-09-15 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof

Publications (3)

Publication Number Publication Date
BRPI0617045A2 BRPI0617045A2 (pt) 2011-07-12
BRPI0617045B1 BRPI0617045B1 (pt) 2020-02-04
BRPI0617045B8 true BRPI0617045B8 (pt) 2021-05-25

Family

ID=36337580

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0617045A BRPI0617045B8 (pt) 2005-09-16 2006-09-15 composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição

Country Status (6)

Country Link
US (3) US7998467B2 (pt)
KR (1) KR101358490B1 (pt)
CN (2) CN104013540A (pt)
AR (1) AR057866A1 (pt)
BR (1) BRPI0617045B8 (pt)
FR (1) FR2890861B1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2890861B1 (fr) * 2005-09-16 2010-05-28 Galderma Res & Dev Compositions comprenant au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethanes ou des derives de celui-ci, leurs procede de preparation, et leur utilisation
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
WO2010093873A2 (en) 2009-02-12 2010-08-19 Incept, Llc Drug delivery through hydrogel plugs
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
FR2944207B1 (fr) * 2009-04-09 2011-05-06 Galderma Res & Dev Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations
WO2014164617A1 (en) * 2013-03-13 2014-10-09 Avon Products, Inc Cosmetic use of napthoic acid derivatives
US9820920B2 (en) * 2014-09-30 2017-11-21 L'oreal High UV protection alcohol-free emulsion system, that is clear on application
CN108504078B (zh) * 2017-02-28 2022-04-19 科思创聚合物（中国）有限公司 一种组合物及其制备方法和应用
US9987239B1 (en) 2017-03-14 2018-06-05 Rey Ventures, LLC Pharmaceutical retinoid preparation for topical use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852437T2 (de) * 1987-07-16 1995-05-04 Univ California Mittel zur Steigerung der Hautpenetration von pharmakologisch aktiven Verbindungen.
JPH061851A (ja) * 1992-06-19 1994-01-11 Toyo Ink Mfg Co Ltd 顔料組成物および水性顔料分散体
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders
FR2890861B1 (fr) * 2005-09-16 2010-05-28 Galderma Res & Dev Compositions comprenant au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethanes ou des derives de celui-ci, leurs procede de preparation, et leur utilisation

Also Published As

Publication number Publication date
KR101358490B1 (ko) 2014-02-06
CN101262862A (zh) 2008-09-10
BRPI0617045A2 (pt) 2011-07-12
AR057866A1 (es) 2007-12-26
FR2890861A1 (fr) 2007-03-23
US20080253986A1 (en) 2008-10-16
CN104013540A (zh) 2014-09-03
FR2890861B1 (fr) 2010-05-28
US8435502B2 (en) 2013-05-07
US8709392B2 (en) 2014-04-29
BRPI0617045B1 (pt) 2020-02-04
US20130245123A1 (en) 2013-09-19
KR20080050579A (ko) 2008-06-09
US20110256078A1 (en) 2011-10-20
US7998467B2 (en) 2011-08-16

Similar Documents

Publication Publication Date Title
BRPI0617045B8 (pt) composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BRPI0609703B8 (pt) compostos de éster de ácido benzóico, composições, usos, e métodos relacionados aos mesmos
GT200600520A (es) Agentes antibacterianos
BRPI0517500B8 (pt) composto, uso de uma composição, composição farmacêutica, composição cosmética, usos não-terapêuticos de uma composição cosmética e processo cosmético para melhorar a aparência da pele
BRPI0902603A8 (pt) uso cosmético de pelo menos um composto ditiolano, composto ditiolano, composição e processo cosmético de preparação da pele para o sol
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
MX2010005516A (es) Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno.
BRPI0600199A (pt) usos de ácido pinolênico ou um seu derivado e de uma composição
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
BRPI0312398B8 (pt) derivado de 1,3-difenilprop-2-en-1-ona substituído, processo de preparação de compostos, composição farmacêutica e utilização de pelo menos um derivado de 1,3-difenilprop-2-en-1-ona substituído
BRPI0914536A8 (pt) Tiadiazoliloxifenilamidinas, processo para sua preparação e seus usos, composição e processo para combater microorganismos indesejáveis, e semente resistente a microorganismos indesejáveis
BRPI0916069C1 (pt) composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BR112012031616A2 (pt) forma cristalina do inibidor de benzilbenzeno sglt2
AR059601A1 (es) Composiciones estables de vitamina c
BRPI0517495A (pt) composição, processo de preparação da composição, uso de uma composição e processo de tratamento cosmético
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/02/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/09/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF